VL
The startup develops a drug-eluting intraocular lens technology that minimizes intraocular inflammation, infection, and opacification during cataract surgery. This lens enhances patient outcomes by eliminating the need for postoperative eye drops and reducing the likelihood of laser treatment.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a drug-eluting intraocular lens technology that minimizes intraocular inflammation, infection, and opacification during cataract surgery. This lens enhances patient outcomes by eliminating the need for postoperative eye drops and reducing the likelihood of laser treatment.